Table 1.
Human AChE | ||||||
---|---|---|---|---|---|---|
OP | R1 | R2 | t (°C) | pH | t1/2 | Reference |
soman * | (CH3)3C(CH3)CHO | CH3 | 27 | 8.0 | 6.3 min | [61] |
sarin | (CH3)2CHO | CH3 | 37 | 8.0 | 3.9 h | [62] |
cyclosarin | cyclohexyl-O | CH3 | 37 | 7.4 | 8.7 h | [63] |
tabun | (CH3)2N | CH3CH2O | 37 | 7.4 | 13.6 h | [64] |
DFP | (CH3)2CHO | (CH3)2CHO | 37 | 7.8 | 4.4 h | [65] |
paraoxon-ethyl | CH3CH2O | CH3CH2O | 37 | 41 h | [63] | |
paraoxon-methyl | CH3O | CH3O | 37 | 7.4 | 3.7 h | [66] |
Human BChE | ||||||
OP | R1 | R2 | t (°C) | pH | t1/2 | |
soman* | (CH3)3C(CH3)CHO | CH3 | 25 | 8.0 | 9 min | [67] |
sarin | (CH3)2CHO | CH3 | 37 | 7.4 | 5.8–6.4 h | [64] |
cyclosarin | cyclohexyl-O | CH3 | 37 | 7.4 | 2.2 h | [63] |
tabun | (CH3)2N | CH3CH2O | 37 | 7.4 | 6.1–6.4 h | [64] |
DFP | (CH3)2CHO | (CH3)2CHO | 37 | 7.8 | 28 min | [65] |
paraoxon-ethyl | CH3CH2O | CH3CH2O | 20 | 8 | 11.6 h | [63] |
paraoxon-methyl | CH3O | CH3O | 37 | 7.4 | 3.9 h | [66] |
racemic soman